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A B S T R A C T
Background
Russia is one of 22 high burden tuberculosis (TB) countries. Identifying individuals,
particularly health care workers (HCWs) with latent tuberculosis infection (LTBI), and
determining the rate of infection, can assist TB control through chemoprophylaxis and
improving institutional cross-infection strategies. The objective of the study was to estimate
the prevalence and determine the relative risks and risk factors for infection, within a vertically
organised TB service in a country with universal bacille Calmette-Gue´rin (BCG) vaccination.
Methods and Findings
We conducted a cross-sectional study to assess the prevalence of and risk factors for LTBI
among unexposed students, minimally exposed medical students, primary care health
providers, and TB hospital health providers in Samara, Russian Federation. We used a novel
in vitro assay (for gamma-interferon [IFN-c]) release to establish LTBI and a questionnaire to
address risk factors. LTBI was seen in 40.8% (107/262) of staff and was significantly higher in
doctors and nurses (39.1% [90/230]) than in students (8.7% [32/368]) (relative risk [RR] 4.5; 95%
confidence interval [CI] 3.1–6.5) and in TB service versus primary health doctors and nurses:
respectively 46.9% (45/96) versus 29.3% (34/116) (RR 1.6; 95% CI 1.1–2.3). There was a gradient
of LTBI, proportional to exposure, in medical students, primary health care providers, and TB
doctors: respectively, 10.1% (24/238), 25.5% (14/55), and 55% (22/40). LTBI was also high in TB
laboratory workers: 11/18 (61.1%).
Conclusions
IFN-c assays have a useful role in screening HCWs with a high risk of LTBI and who are BCG
vaccinated. TB HCWs were at significantly higher risk of having LTBI. Larger cohort studies are
needed to evaluate the individual risks of active TB development in positive individuals and the
effectiveness of preventive therapy based on IFN-c test results.
The Editors’ Summary of this article follows the references.
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Introduction
Identifying individuals with latent tuberculosis infection
(LTBI) (considered to be persistence and multiplication of
viable Mycobacterium tuberculosis bacilli within macrophages
but without clinical manifestation of disease [1]) and their
subsequent chemoprophylaxis is an important measure in
preventing the development of active tuberculosis (TB),
which can help to reduce the overall incidence and spread
of TB.
Russia is one of the 22 World Health Organization-deﬁned
high-incidence TB countries; high rates of drug resistance,
including multi-drug resistance have been reported from
several regions [2–4].
Bacille Calmette-Gue´rin (BCG) vaccination is national
policy in Russia and is administered to newborn babies and
then repeated at 7 and 14–15 years of age [5]. The repetitive
administration of BCG (and possibly also hypersensitisation
from multiple annual tuberculin [PPD] screens) makes
diagnosis of LTBI using traditional tuberculin skin tests
(TSTs) in Russia challenging.
Similarly, health care workers (HCWs), particularly those
working with patients with TB, are at a high risk of
developing TB as a consequence of the vertical TB manage-
ment programme (the TB service is distinct from the
pulmonology and infectious disease services), prolonged
hospitalisation of TB patients, the lack of isolation facilities,
and weak infection control measures.
The general TB incidence rate in Samara Oblast in 2004, a
region in Russia with a population of 3.3 million (Samara
City, the capital has a population of 1.3 million), was 69.3/
100,000, but TB incidence among TB staff was 741.6 per
100,000 [6]. No information is available for rates of LTBI in
this group, largely due to the methodological problems
associated with interpreting TST in a population that is
universally immunised for BCG (commonly twice) and will
have had multiple annual PPD examinations throughout
childhood. High rates of LTBI would support the need for the
review and reinforcement of institutional cross-infection
measures.
Novel tests for latent infection have been developed based
on the measurement of gamma-interferon (IFN-c) produc-
tion from peripheral blood mononuclear cells in response to
two M. tuberculosis secreted proteins, ESAT-6 and CFP-10,
absent in the vaccine strain BCG [7,8]. Two commercial
systems (QuantiFERON–TB Gold, Cellestis, http://www.
cellestis.com and T-Spot; Oxford Immunotec, http://www.
oxfordimmunotec.com) have been used and reported to
provide more sensitive and speciﬁc detection of latent and
subclinical forms of TB than do traditional TSTs [7,9].
However, these systems have not been extensively tested for
detection of LTBI in HCWs in a high TB incidence region
against a background of universal BCG vaccination.
The aim of this study was to estimate the prevalence of
latently infected clinical staff within the TB service (high-
exposure group), in comparison to students prior to their
employment (low-exposure group), and other clinical staff
not primarily working with TB patients (medium exposure),
and to test our hypothesis that infected cases increase in
proportion to increasing occupational exposure to TB.
Furthermore, we aimed to determine the relative risks and
risk factors for infection.
Methods
We conducted a comprehensive cross-sectional study of
LTBI amongst clinical staff and students from October 2004
until October 2005 in Samara City. The prevalence of LTBI
was established in three exposure groups: low (medical
students from Samara Medical University [n ¼ 238] and
nonmedical students [n¼ 130] from Samara State University),
intermediate (primary care physicians and nurses), and high
(TB service doctors and nurses). Each of the participants gave
written informed consent. The study was approved by the
ethics committee of Samara State Medical University. Each
participant completed a structured questionnaire providing
information on possible risk factors for LTBI including
demographic and socioeconomic details, presence of BCG
scars, and degree of occupational exposure (year of training
and active clinical/nursing practice in the TB or primary care
service, job category, and nonmedical tuberculosis contact).
Everyone identiﬁed as LTBI positive within the medical
service was offered information on the published sensitivity
and speciﬁcity of the tests, the potential value of these tests,
and counselling on the risks and beneﬁts of chemoprophy-
laxis. Within Samara, and Russia as a whole, chemoprophy-
laxis of household contacts is uniformly given. However, at
present these IFN-c tests are not licensed in the Russian
Federation, and there are no guidelines on the use of these
tests in the Russian Federation.
As the goal of the study was to recruit all clinical TB
health care workers (HCWs) in Samara, no formal sample
size determination was needed. TB staff were recruited from
all TB clinics in the city; primary HCWs were recruited
from a large polyclinic in Samara (Polyclinic 15). Polyclinics
are the key primary care service providers and are
organised on a per capita basis so that the polyclinic
sampled would be representative of polyclinics across the
city, particularly as we enrolled as close to all of the clinical
staff as possible.
Blood samples (n ¼ 630) from all participants were
screened using a novel ex vivo IFN-c release assay by drawing
blood directly into QuantiFERON–TB Gold In-Tubes (Cel-
lestis) containing ESAT-6 and CFP-10 antigens absent from
BCG. Tubes were incubated at 37 8C overnight before
centrifugation, and IFN-c release was measured by ELISA
as described by the manufacturer at the Samara Regional
Tuberculosis Laboratory. All the assays performed met the
manufacturer’s quality control standards. Thirty plasma
samples (4.8% of the total of 630 tested) were retested at
the HPA Mycobacterium Reference Unit, London, and the
concordance was 100%.
Statistical analysis was performed using the SPSS version
12 package (SPSS, http://www.spss.com). The difference of
means was detected using Student’s t-test. The difference
between positivity rates among different groups was assessed
using Pearson’s Chi2 test (the groups were regarded as
ordinal with increasing level of exposure from students to
primary health care workers and TB workers groups). Risk
factors for test positivity were deﬁned using an odds ratio
(OR) and relative risk (RR). Possible confounding effects
between some of the variables, i.e., age and years of medical
practice, were examined and accounted for. Only doctors
and nurses were included in the risk factor analysis as
‘‘support staff,’’ and ‘‘others’’ (e.g., ward receptionists) were
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not recruited according to the original study protocol; they
requested inclusion after the study had commenced as they
felt they were also a heavily exposed group. To adjust for
multiple covariates, we used an unconditional binary logistic
regression model with IFN-c test results as the outcome and
covariates, such as markers of tuberculosis exposure. All
variables included in the multivariate analysis were deter-
mined a priori based on estimation of their signiﬁcance as
epidemiological factors during the preliminary crude analysis
(signiﬁcant at p  0.05 and Pearson’s correlation coefﬁcient
, 0.30) and biological plausibility. Model ﬁt was evaluated
using the Hosmer-Lemeshow test.
Results
We recruited 630 individuals in total (598 directly recruited
and 32 support workers who themselves requested testing but
were not included in the ﬁnal analysis) into the study; within
the TB service 114/114 (100%) of all doctors and nurses; and
116/120 (96.7%) of those working in the polyclinic (Table 1).
The prevalence of LTBI was determined in a low exposure
group (n ¼ 368) comprised of medical students in their ﬁnal
two years (245 students were invited to take part and 238
[97.1%] did so) and nonmedical students in their ﬁnal year
(130/130 [100%] participated) to establish the baseline
Table 1. Baseline Characteristics of Student and Health-Care Groups
Characteristics Specific
Characteristics
Control (Nonmedical
Students) (n ¼ 130)
Medical Students
(n ¼ 238)
Primary Care
Staff (n ¼ 122)
TB Staff (n ¼ 140)
Sex male/female 51 (39.2%) 79 (60.8%) 82 (34.5%) 156 (65.5%) 5 (4.1%) 117 (95.9%) 13 (9.3%) 127 (90.7%)
Mean age (range) 19.9 y (17–24 y) 21.0 y (18–32 y) 42.1 y (20–69 y) 48.9 y (24–75 y)
Menopause in females 0 0 24/177 (13.6%) 63/127(49.6%)
Born in Samara 104 (80.0%) 139 (58.4%) 75 (61.5%) 93 (66.4%)
BCG 113 (86.9%) 209 (87.8%) 116 (95.1%) 97 (69.3%)
Taking any non-TB
antibiotics
13 (10.0%) 7 (2.9%) 5 (4.1%) 1 (0.7%)
Lung diseases 6 (4.6%) 11 (4.6%) 12 (9.8%) 11 (7.9%)
Diabetes 0 0 3 (2.5%) 1 (0.7%)
Contact with animals 85 (65.4%) 145 (60.9%) 70 (57.4%) 80 (57.1%)
Accommodation House 5 (3.8%) 16 (6.7%) 3 (2.5%) 12 (8.6%)
Apartment 56 (43.1%) 134 (56.3%) 108 (88.5%) 115 (82.1%)
Communal flat 2 (1.5%) 5 (2.1%) 8 (6.6%) 7 (5.0%)
Hostel 67 (51.5%) 83 (34.9%) 3 (2.5%) 6 (4.3%)
TB in the past 0 0 0 24 (17.1%)
TB therapy in the past 0 0 0 24 (17.1%)
Casual contact with a
TB patient
0 0 13 (10.7%) 15 (10.7%)
Work at medical
institution
2 (1.5%) 43 (18.1%) 122 (100%) 140 (100%)
Average years of clinical
practice (mean, SD)
0.02 (0.1) 0.4 (1.2) 18.2 (11.3) 20.1 (10.7)
Work at TB institution 0 (0%) 0 (0%) 2 (1.6%) 140 (100%)
Smoker 49 (37.7%) 67 (28.2%) 14 (11.5%) 14 (10.0%)
Ex-smoker 4 (3.1%) 8 (3.4%) 0 0
Mean number of
cigarettes per
day (SD)
9.7 (6.5) 9.1 (5.3) 6.7 (6.2) 13.4 (6.6)
Mean years of
smoking (SD)
3.5 y (2.5 y) 4.4 y (2.9 y) 11.0 y (7.6 y) 22.6 y (9.9 y)
Since what age,
mean (SD)
16.6 y (2.3 y) 16.5 y (2.9 y) 21.4 y (5.5 y) 21.4 y (7.3 y)
Never smoked 55 (42.3%) 119 (50.0%) 77 (63.1%) 110 (78.6%)
History of hepatitis B/C 1 (0.8%) 2 (0.8%) 3 (0.3%) 7 (0.5%)
Blood transfusion 0 (0%) 0 (0%) 11 (9.0%) 10 (7.1%)
Born outside
Samara region
26 (20.0%) 101 (42.4%) 47 (38.5%) 47 (33.6%)
Place of birth Russia 16 (12.3%) 69 (29.0%) 31 (25.4%) 35 (25.0%)
Ukraine 1 (0.8%) 3 (1.3%) 3 (2.5%) 2 (1.4%)
Byelorussia 0 (0%) 1 (0.4%) 2 (1.6%) 0 (0%)
Central Asia (Kyrgyzstan,
Tajikistan, Turkmenistan,
Uzbekistan, Kazakhstan)
6 (4.6%) 11 (4.6%) 4 (3.3%) 9 (6.4%)
Caucasus (Armenia, Georgia,
Azerbaijan, Chechnya)
0 (0%) 10 (4.2%) 3 (2.5%) 0 (0%)
Bashkortostan 2 (1.5%) 7 (2.9%) 1 (0.8%) 1 (0.7%)
Tatarstan 1 (0.8%) 0 (0%) 3 (2.5%) 0 (0%)
‘‘Casual’’ contact is defined as brief contact outside of professional/training exposure.
doi:10.1371/journal.pmed.0040055.t001
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prevalence, and whether the prevalence was broadly similar
in both student groups. None of the participants had active
TB, conﬁrmed by absence of symptoms and recent chest
radiography (all students and primary HCW within the
previous 12 months). All TB staff underwent ﬂuorographic
and/or chest radiological screening biannually. None of the
students or staff participants had experience working at TB
facilities beyond short rotations (two three-week rotations in
the preceding two years) in the TB service. Signiﬁcantly, more
medical students were born outside Samara Oblast (RR 2.1;
95% conﬁdence interval [CI] 1.5–3.1) compared to non-
medical students, but no differences were detected between
primary care and TB staff in this respect.
Baseline characteristics and absolute numbers of staff are
given in Tables 1 and 2. Among health professionals the
median number of years of clinical work was 18.2 and 20.1 y
for primary care and TB staff, respectively.
The proportion of doctors and nurses among primary care
workers and TB workers was similar; nonclinical staff were
included in the descriptive analysis at this stage but as their
recruitment was outside the planned strategy (they self-
referred) they were not included in the univariate and
multivariate analyses.
Although the LTBI rate in medical students (10.1%)
appeared higher than in nonmedical students (6.2%) (pre-
sumably reﬂecting some exposure during their studies), this
was not statistically signiﬁcant, and none reported speciﬁc TB
contact in their questionnaire. The majority of the partic-
ipants had had BCG vaccination. Nevertheless, levels of
positivity were relatively high (6.2% and 10.1%, respectively)
for young people with apparently little contact with TB cases
and not working in the area of TB control; it likely reﬂects
general exposure in a high TB burden country. None of the
students reported having an immunosuppressive condition
or active TB, or were taking immunosuppressive drugs.
Across students, primary care workers, and TB staff, a
trend for increased positivity was observed (v2 for trend was
104.4, p , 0.001). The proportion of LTBI reﬂected by
positive IFN-c test was signiﬁcantly higher in health care
workers compared to the control group (all students), with
39.1% of all doctors and nurses being positive (versus 8.7% in
students, RR 4.5 [95% CI 3.1–6.5]). Table 2 demonstrates the
rates of IFN-c positivity in different groups, and Table 3
Table 2. Number and Percentage Positive LTBI (IFN-c Assay) by Exposure Group, Samara Oblast
Category Group Number Positive (%; 95% CI)
Nonmedical students (n ¼ 130) 8 (6.2%; 2.9%–11.3%)
Medical students (n ¼ 238) 24 (10.1%; 6.7%–14.4%)
All students (n ¼ 368) 32 (8.7%; 6.1%–11.9%)
Primary care staff (n ¼ 122) 38 (31.1%; 23.4%–39.8%)
Doctors (n ¼ 55) 14 (25.5%; 15.3%–38.2%)
Nurses (n ¼ 61) 20 (32.8%; 21.9%–45.3%)
Doctors and nurses (n ¼ 116) 34 (29.3; 21.6%–38.1%)
Ward support staff (n ¼ 2) 2 (100%; 22.4%–100.0%)
Others (drivers, administrators) (n ¼ 4) 2 (50.0%; 9.4%–90.6%)
TB staff (n ¼ 140) 69 (49.3%; 41.1%–57.5%)
Doctors (n ¼ 40) 22 (55.0%; 39.5%–69.8)
Nurses (n ¼ 56) 23 (41.1%; 28.8%–54.3%)
Lab staff (n ¼ 18) 11 (61.1%; 37.7%–81.1%)
Doctors and nurses (n ¼ 96) 45 (46.9%; 37.1%–56.9%)
Ward support staff (n ¼ 16) 10 (62.5%; 37.6%–83.2%)
Others (drivers, administrators) (n ¼ 10) 3 (30.0%; 8.3%–62.0%)
All health care staff (n ¼ 262) 107 (40.8%; 35.0%–46.9%)
All doctors and all nurses (includes lab staff
without support staff and others) (n ¼ 230)
90 (39.1%; 33.0%–45.6%)
All doctors only (n ¼ 95) 36 (37.9%; 28.6%–47.9%)
doi:10.1371/journal.pmed.0040055.t002
Table 3. Relative Risk (%) and 95% Confidence Intervals of LTBI
Positivity (IFN-c) by Exposure Group, Samara Oblast
Group v2 RR (95% CI)
Medical students versus nonmedical students 1.6 1.6 (0.8–3.5)
All health care staff versus all students 92.0 4.7 (3.3–6.7)
All doctors and nurses versus all students 39.1 4.5 (3.1–6.5)
All doctors versus all students 51.4 4.4 (2.9–6.6)
All health care staff versus medical students 61.0 4.1 (2.7–6.1)
All doctors and nurses versus
medical students
53.6 3.9 (2.6–5.9)
All doctors versus medical students 35.6 3.8 (2.4–5.9)
Primary care staff versus all students 37.7 3.6 (2.4–5.5)
Primary care doctors versus all students 13.9 2.9 (1.7–5.1)
Primary care doctors and nurses
versus all students
31.8 3.4 (2.2–5.2)
Primary care staff versus medical students 25.1 3.1 (2.0–4.9)
Primary care doctors and nurses
versus medical students
21.0 2.9 (1.8–4.7)
Primary care doctors versus medical students 9.4 2.5 (1.4–4.6)
TB staff versus primary care staff 8.9 1.6 (1.2–2.2)
TB staff versus all students 104.9 5.7 (3.9–8.2)
TB doctors and nurses versus all students 80.2 5.4 (3.6–8.0)
TB doctors versus all students 67.4 6.3 (4.1–9.8)
TB staff versus medical students 73.0 4.9 (3.2–7.4)
TB doctors and nurses versus
medical students
56.5 4.7 (3.0–7.2)
TB doctors versus medical students 50.0 5.5 (3.4–8.7)
TB doctors and nurses versus primary
care doctors and nurses
6.9 1.6 (1.1–2.3)
doi:10.1371/journal.pmed.0040055.t003
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compares the differences in proportions of IFN-c-positive
individuals between exposure groups.
The mean IFN-c concentration (standard deviation [SD]) in
control students, medical students, primary care doctors and
nurses, and TB doctors and nurses was 1.8 (1.9) IU/ml, 4.2 (5.0)
IU/ml, 7.8 (7.3) IU/ml, and 3.0 (3.6) IU/ml, respectively. There
was no correlation between the level of IFN-c and age, nor
level of IFN-c and number of years of medical practice
overall.
The proportion of people diagnosed with LTBI was
signiﬁcantly higher among primary health care doctors and
nurses compared to the low-exposure group of medical
students (29.3% versus 10.1%, RR 2.9 [95% CI 1.8–4.7]) and in
TB doctors and nurses compared to primary health care
workers or medical students (46.9% versus 29.3%, RR 1.6
[95% CI 1.1–2.3] and versus 10.1%, RR 4.7 [95% CI 3.0–7.2]).
Statistically signiﬁcant differences in the proportions of
individuals with LTBI were found between medical students,
primary doctors, and TB doctors speciﬁcally as well as
between all students, all primary care staff, and all TB clinical
staff, reﬂecting the gradient of increased TB exposure (Table
3).
We also identiﬁed risk factors for LTBI among students,
doctors, and nurses. The univariate analysis demonstrated
that among all students there were no signiﬁcant predictors
of positivity. Among doctors and/or nurses (working in
general care and the TB service), age over 35 years, TB in
the past, work in a TB clinic, and more than ﬁve years in
medical practice were associated with having LTBI on
univariate analysis (OR 3.1, 95% CI 1.5–6.4; OR 2.8, 95% CI
1.1–7.0; OR 2.6, 95% CI 1.5–4.4; and OR 2.5, 95% CI 1.4–5.0
and correlation coefﬁcients of 0.136, p ¼ 0.002; 0.148, p ¼
0.025; 0.225, p ¼ 0.001; and 0.114, p ¼ 0.003, respectively).
Gender was not associated with a positive test result.
Multivariate analysis demonstrated that work in a TB clinic
was the only signiﬁcant risk factor for LTBI (OR 1.9, 95% CI
1.1–3.5, p ¼ 0.031).
Discussion
This is the ﬁrst study, to our knowledge, to directly
establish rates of TB infection in HCWs in any former Soviet
Union country using novel direct in-tube in vitro IFN-c
assays. QuantiFERON–TB Gold In-Tube assays are as sensi-
tive and more speciﬁc than traditionally used PPD tests,
varying between 59% and 89%, and 53% and 100%,
respectively [10–15]. Nearly everyone who was invited to
participate in the study did so, reﬂecting an interest in and a
level of awareness of the problem of TB.
In vitro IFN-c assays are likely to be of particular value in
determining LTBI in former Soviet Union countries because
of the practice of giving multiple BCG vaccinations, previous
repetitive TSTs in childhood, and an existing annual screen-
ing policy for TB in health care workers [16].
The study supports our hypothesis that there was a high
prevalence of LTBI in staff within the TB service (i.e., a high-
exposure group), including those working in the laboratory
compared to students (low-exposure group), and clinical staff
(doctors and nurses) working in primary practice (intermedi-
ate exposure). A high proportion of self-referred support
staff were also LTBI positive. An increasing proportion of
infected individuals were seen with increasing occupational
health exposure to TB.
The multivariate analysis demonstrated that work in a TB
service was the only important risk factor for LTBI, reﬂecting
extensive exposure to M. tuberculosis. Our study supports
previous evidence that results of ESAT-6 and CFP-10 based
IFN-c tests results are not affected by BCG vaccination [11],
particularly relevant in a country where repetitive BCG
vaccination is national policy.
Our results are consistent with recently published results of
two studies in HCWs from a high- (India) and a low- (Japan)
incidence country [14,17,18], but these were in single
institutions. Similar risk factors for infection were demon-
strated at a hospital in India using these assays [17] and in
previous skin test surveys of HCWs in India using PPD, which
were likely confounded by BCG vaccination.
The study emphasises the importance of studying LTBI in
all HCW, as infection rates were high in an intermediate-risk
group (primary care) as well as in a high-risk group (TB health
workers); as TB patients are treated in a distinct vertical TB
service, we were able to clearly deﬁne HCW groups with
different TB exposure and contrast these with students.
Although not strictly a sample-based strategy, the present
group of students, doctors, nurses, and laboratory staff, in
particular those working in the TB service, are at increased
risk of infection, suggesting that appropriate preventive
strategies and/or staff health monitoring should be under-
taken. HCWs in this region of Russia are likely to be
representative of Russia as a whole, as the organization of
the health system in Samara is almost identical to that of
Russia and is similar to all countries of the former Soviet
Union. Similarly, the TB incidence and prevalence is close to
the national average for Russia [4].
The IFN-c-based assays appear to offer rapid in vitro
testing requiring a single screening visit, which is less
subjective than skin testing and can be repeated as an annual
occupational screening. Improved institutional cross-infec-
tion strategies and subsequent preventive therapy for those
infected will be of value to health professionals and their
patients. However, the reagent cost of the test is high,
requiring an appropriate laboratory infrastructure, and the
samples need to be processed within a short period of time.
The ﬁndings in this study should also help to inform
occupational health policy in countries such as Russia and the
United States, where there is an annual screening of health
care staff for TB using chest X-ray (Russia), and Mantoux
testing (United States), or no clear annual policy (such as the
United Kingdom). IFN-c assays demonstrate good perform-
ance in serial testing [19] and therefore could have a useful
role in regular screening of HCWs and students with a high
risk of LTBI, particularly where recent infection is demon-
strated. Nevertheless, larger cohort studies are needed to
assess the value of these tests results, risks of active TB
development in positive individuals, and effectiveness of
preventive therapy based on IFN-c test results.
The key question globally will be how these results are used.
In the Russian context the results will be of greatest value in
modifying institutional infection control and occupational
health policies, which have traditionally been weak. Negative-
pressure facilities are not usually available in Russian
hospitals, including those centres dealing exclusively with
TB, unlike the United States or most parts of Western
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Europe; the main feature of TB control is the use of
ultraviolet germicidal radiation and daily surface disinfec-
tion. A similar practice operates in the laboratories. Except in
winter, windows are opened to provide ventilation.
Individually, preventive therapy given to those with a
positive tuberculin test substantially decreases the risk of
development of active TB [20]. However, there has been no
trial to demonstrate the efﬁcacy and cost-effectiveness of
administration of preventive therapy based on IFN-c test
results, although it would be reasonable to suppose that there
would be some beneﬁt. For example, chemoprophylaxis
following positive TSTs outside Russia is limited largely to
younger age groups. In Russia it is widely practised for
children and for close contacts of patients with active TB
(without conducting a TST, because of the high probability of
false-positive results in adults). All HCW staff are radio-
logically screened for TB annually with referral to the TB
service for chemoprophylaxis or full treatment as appropri-
ate. Within the TB service, isoniazid prophylaxis is not widely
practised, as there is an argument that it would be of limited
value due to the continued exposure to new cases.
The value of chemoprophylaxis in Samara will be reduced
by the high prevalence of isoniazid and multidrug-resistant
tuberculosis reported there (as these tests cannot distinguish
between infection with drug sensitive and resistant organ-
isms) [3,4] and elsewhere in Russia [21]; nevertheless, the
majority of individuals will still have been infected with
susceptible organisms, and it is not known how extensive
drug resistance is across the Russian population, as well-
designed drug resistance surveys have only been reported for
a few regions of the Russian Federation. Indeed a study in
Orel, Russia demonstrated a relatively low incidence of drug
resistance [22]. Furthermore, chemoprophylaxis may be more
effective in Samara and comparable regions for addressing
latent infection than active disease due to the small bacterial
organism load where the relevant population of drug
resistant organisms are a small proportion of a low number
of bacteria; these organisms may be destroyed or controlled
by the individual’s cell immune system. There is some
anecdotal evidence for this in that there have been very few
active cases of TB reported in TB contacts in Samara, given
empirical chemoprophylaxis.
In contrast, in the United States, guidelines from the
Centers for Disease Control (CDC) [23] suggest that the Food
and Drug Administration (FDA) approved QuantiFERON–TB
Gold assay can be used wherever Mantoux testing would be
employed, with the assumption that chemoprophylaxis will be
applied in the same way and with similar efﬁcacy. This study,
using the QuantiFERON–TB Gold In-Tube method (which is
awaiting FDA approval) will help determine policy in those
countries where BCG vaccination is used (the majority).
Although studies have demonstrated the beneﬁts of using
IFN-c tests in low-incidence countries where a new positive
result appears to demonstrate recent infection [24], in
middle- to high-incidence countries the high number of
positive individuals may make wide scale chemoprophylaxis
unworkable. Ultimately, the ability to deliver an effective and
appropriate chemoprophylaxis strategy is essential if these
tests are to be of real clinical and public health beneﬁt.
Further economic studies are also needed to evaluate the
cost-effectiveness of using these tests in middle-income high-
incidence countries as well as low-incidence countries such as
the United Kingdom and the United States.
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Editors’ Summary
Background. Tuberculosis (TB) is a very common and life-threatening
infection caused by a bacterium, Mycobacterium tuberculosis, which is
carried by about a third of the world’s population. Many people who are
infected do not develop the symptoms of disease; this is called ‘‘latent
infection.’’ However, it is important to detect latent infection among
people in high-risk communities, in order to prevent infected people
from developing active disease, and therefore also reduce the spread of
TB within the community. 22 countries account for 80% of the world’s
active TB, and Russia is one of these. Health care workers are particularly
at risk for developing active TB disease in Russia, but the extent of latent
infection is not known. In order to design appropriate measures for
controlling TB in Russia, it is important to know how common latent
infection is among health care workers, as well as other members of the
community.
Why Was This Study Done? The researchers here had been studying
the spread of tuberculosis in Samara City in southeastern Russia, where
the rate of TB disease among health care workers was very high; in 2004
the number of TB cases among health care workers on TB wards was
over ten times that in the general population. There was also no
information available on the rates of latent TB infection among health
care workers in Samara City. The researchers therefore wanted to work
out what proportion of health care workers in Samara City had latent TB
infection, and particularly to compare groups whom they thought would
be at different levels of risk (students, clinicians outside of TB wards,
clinicians on TB wards, etc.). Finally, the researchers also wanted to use a
new test for detecting latent TB infection. The traditional test for
detecting TB infection (tuberculin skin test) is not very reliable among
people who have received the Bacillus Calmette-Gue´rin (BCG) vacci-
nation against TB earlier in life, as is the case in Russia. In this study a new
test was therefore used, based on measuring the immune response to
two proteins produced by M. tuberculosis, which are not present in the
BCG vaccine strain.
What Did the Researchers Do and Find? In this study the researchers
tested health care workers from all the TB clinics in Samara City, as well
as other clinical staff and students, for latent tuberculosis. In total, 630
people had blood samples taken for testing. A questionnaire was also
used to collect information on possible risk factors for TB. As expected,
the rate of latent TB infection was highest among clinical staff working in
the TB clinics, 47% of whom were infected with M. tuberculosis. This
compared to a 10% infection rate among medical students and 29%
infection rate among primary care health workers. The differences in
infection rate between medical students, primary care health workers,
and TB clinic staff were statistically significant and reflected progressively
increasing exposure to TB. Among primary care health workers, past
exposure to TB was a risk factor for having latent TB infection.
What Do These Findings Mean? This study showed that there was a
high rate of latent TB infection among health care workers in Samara City
and that infection is increasingly likely among people with either past or
present exposure to TB. The results suggest that further research should
be carried out to test whether mass screening for latent infection,
followed by treatment, will reduce the rate of active TB disease among
health care workers and also prevent further spread of TB. There are
concerns that widespread treatment of latent infection may not be
completely effective due to the relatively high prevalence of drug-
resistant TB strains and any new initiatives would therefore need to be
carefully evaluated.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/doi:10.1371/journal.pmed.
0040055.
 The Stop TB Partnership has been set up to eliminate TB as a public
health problem; its site provides data and resources about TB in each
of the 22 most-affected countries, including Russia
 Tuberculosis minisite from the World Health Organization, providing
data on tuberculosis worldwide, details of the Stop TB strategy, as well
as fact sheets and current guidelines
 The US Centers for Disease Control has a tuberculosis minisite,
including a fact sheet on latent TB
 Information from the US Centers for Disease Control about the
QuantiFERON-TB Gold test, used to test for latent TB infection in this
study
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